Online Menopause Second Opinion: Your Options When You’ve Been Dismissed

We may earn a commission from some provider links. Provider order reflects fit for this page’s situation and The HRT Index Verification Standard, not payout. See our full affiliate disclosure.

So here’s the quick version, by what you’re looking for:

• Want ongoing, insurance-based care? Midi Health fits many commercially insured women who want a live menopause visit.
• Want one cash-pay video visit with basic labs included if ordered? Sesame fits.
• Want a true one-and-done second opinion? Evernow’s Pay-per-Visit is built for exactly that. (It’s not one of our partners — we’ll explain why we list it anyway.)
• Have a red flag like unexplained bleeding, a clot or cancer history, or a possible pregnancy? See someone in person first. We’ll show you the full list below.

That’s the bottom line. Now the part the provider websites won’t tell you, because they’re selling you their own visit: not every “online menopause provider” is actually a second opinion. Some put you on a video call with a clinician who reviews your case. Others are a questionnaire that ends in a prescription. Both can be legitimate care. Only one is a second opinion — and below, we show you which is which, what each costs, and the one thing to check before you pay.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

One thing up front:this page doesn’t tell you to start, stop, or change HRT on your own. A second opinion is a clinician’s review— not a workaround. The goal is to get you a clear, qualified answer, and to be honest with you about when that answer needs to come from an in-person visit.

What we actually verified for this page (June 2026)

We read each provider’s own pricing, care model, insurance status, and whether they prescribe FDA-approved or compounded hormones — straight from their sites. We traced every medical statement to the FDA, The Menopause Society, or peer-reviewed research. We have not test-driven every checkout, so confirm prices when you sign up. Some links are affiliate links; our verdicts follow The HRT Index Verification Standard, not commissions. We never use fake reviews, fake star ratings, or paid-placement ranking. Non-partner providers (Evernow, Gennev) are listed because they’re the honest answer for certain situations.

Last updated: June 2026  ·  Last verified: June 2026

Start here: if this is why you searched

A second opinion usually starts with a specific moment — a doctor said something that didn’t sit right. Find your situation, then read on for the details.

The right online HRT provider isn’t the same for every woman— it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first.

Tells you whether online care is your right first step, flags when to see someone in person, and points you to the provider model that fits you. (Free.)

Can you get a menopause second opinion online?

The difference that matters is howthe provider works. A live video visit with a menopause-trained clinician is a real second opinion: someone listens, asks questions, and can disagree with or refine the plan you were given. A questionnaire-only service is something else — a fast way to get a prescription, not a conversation. Here’s how the main options actually compare.

Which online services actually work as a second opinion?

So the column that matters most below isn’t price. It’s “Do you get a live visit, or just a prescription?”

Last verified June 2026. Confirm all prices at checkout — we don’t guess or use fake “starting at” math.

We list Evernow and Gennev even though they don’t pay us, because a decision resource that hides the best-fit option isn’t a decision resource. If you want a true one-and-done second opinion, Evernow’s Pay-per-Visit is literally built for it. If you want a physician-led, insurance-based visit, Gennev’s network is OB/GYNs (many menopause-certified).

If you have insurance and want a real review: Midi Health

If you want one clear cash visit with labs: Sesame

If you want a true one-and-done second opinion: Evernow not a partner

If you already know you want to start, fast: Winona

Two narrower options

• Hers offers FDA-approvedestradiol and progesterone through an intake a provider reviews. It’s a fine option if you already like the Hers app — but it’s not available in all 50 states, and for perimenopause, hormone therapy is prescribed off-label, so check your state and confirm the current price first. Check availability and price at Hers →
• Inner Balance (Oestra) is a compoundeddaily vaginal cream that combines estradiol and progesterone, listed at $99.50/month. It’s a niche pick for a woman who specifically wants a single compounded cream — not a general second-opinion route, and not FDA-approved. Confirm whether it’s available in your state at checkout. (Source: Inner Balance, June 2026.) See Inner Balance →

Is an online menopause second opinion worth it?

Let’s sit with that, because it might be the most validating thing you read today.

You were not imagining it. In a 2019 survey of family-medicine, internal-medicine, and OB/GYN residents published in the journal Menopause, about 20% had received no menopause lectures at all during training, and only 6.8% felt adequately prepared to care for menopausal patients. Most strikingly, 34% said they would not offer hormone therapy to a symptomatic, newly menopausal woman who had no medical reason to avoid it (Kling et al., 2019). A 2023 survey found only about 31% of OB/GYN residency programs even included menopause in training (Allen et al., 2023, Menopause).

The gap shows up in the numbers. The FDA notes that in 2020, about 41 million U.S. women were ages 45–64, while only about 2 million women ages 46–65 receiveda hormone-therapy prescription (FDA, 2026). And it’s not for lack of need — research cited by the FDA estimates that about a third of women in this age range have moderate-to-severe hot flashes and night sweats.

So if your visit felt rushed, or you were told “that’s just aging,” or “you’re too young,” or you were handed an antidepressant before anyone mentioned hormones — a second opinion isn’t being difficult. It’s catching up to where the science already is.

Was your doctor wrong — or appropriately cautious?

Here’s the honest truth most pages skip: a good second opinion sometimes agreeswith the first one. That’s still a win — now you know. Read your situation on the left, then what current guidance (The Menopause Society, 2022, and the FDA, 2025–2026) actually says.

When online care is the wrong starting point

We’d rather lose you here than have you start in the wrong place. A trustworthy provider should tell you the same — and if an online service tries to keep you in its funnel when you describe a red flag, that’s a sign to walk away.

These mirror the situations the FDA and The Menopause Society flag as reasons not to use hormone therapy without close medical guidance. And here’s a useful trust test: a good online provider, hearing one of these, should do one of a few things — keep reviewing your case online, ask for your records, order labs, refer you in person, or decline online treatment and tell you plainly why. A provider that ignores a red flag to make a sale is the wrong provider.

Find My HRT Path — if a red flag is you, it says so, and you can bring the summary to an in-person visit. (Free.)

FDA-approved or compounded? What your second opinion should clarify

Here’s the plain-English version. Compoundedmeans made-to-order at a compounding pharmacy. It’s legal, and it has a real place — for example, if you’re allergic to a filler in a standard product, or need a dose that isn’t manufactured. But “compounded” and “FDA-approved” are not the same thing. And “bioidentical” isn’t an FDA approval category— it describes the chemistry (hormones built to match the ones your body makes), not whether a product is FDA-approved. In fact, several FDA-approved products arechemically identical to your own hormones. So no one should tell you a compounded cream is “the same as” or “safer than” an FDA-approved patch. They’re different categories, full stop.

A good second opinion should make this crystal clear. Questions worth asking:

• “Is this exact product FDA-approved, or compounded?”
• “If it’s compounded, why are we choosing that over an FDA-approved option?”
• “Which pharmacy makes it, and how is it tested?”
• “What would make us switch to an FDA-approved version?”

If you want FDA-approved-only or insurance-friendly care, lean toward Midi, Sesame, Hers, Evernow, or Gennev. If you specifically want a compounded formula, that’s a real option too — just make sure it’s labeled honestly and prescribed by a clinician who explains the trade-off. Winona’s creams and Inner Balance/Oestra are compounded; Winona’s patch, tablet, and progesterone capsule are the FDA-approved exceptions. Want help sorting which fits you? Our FDA-approved vs. compounded HRT guide breaks it down, or filter for FDA-approved options in Find My HRT Path.

Can you get HRT online after being told no?

What the process usually looks like: you fill out an intake, meet a clinician (live, on the good ones), they may order labs, and if it’s appropriate, a prescription goes to your pharmacy or ships to you. The right outcome might be hormones — or it might be a different dose, a non-hormonal option, more testing, or an in-person referral. That’s not the system failing. That’s it working.

One important note on testosterone: some women ask about it for low libido. In the U.S., testosterone is a Schedule III controlled substance. It always requires a prescription and proper medical oversight — no legitimate provider hands it out casually, online or off. There’s also no FDA-approved testosterone product made for women, so any use is off-label and a conversation to have with a clinician.

(Free.)

Does insurance cover an online menopause second opinion?

Bills commercial insurance for visits:

• Midi— in-network with most PPO plans (you pay a copay).
• Gennev— Aetna, Anthem, and UnitedHealthcare.
• Evernow— says its video visits are insurance-eligible; confirm your plan.

Cash-pay (no insurance billing; HSA/FSA usually works):

• Sesame, Winona, Hers, Inner Balance/Oestra.Your medication can still be cheaper through your pharmacy’s insurance, and these often beat a copay anyway.

Can I use Medicare or Medicaid?

How much does an online menopause second opinion cost?

One money tip from our research: the cheapest first month isn’t always the cheapest year. A low-cost service with no real follow-up can cost more over time if it skips the check-ins hormones actually need. Look at the wholepicture — visit, medication, labs, and follow-up — not just the headline price. (For the full breakdown, see our HRT cost guide.)

What should you bring to an online menopause second opinion?

Walk in with this and you’ll turn a 30-minute visit into a real review:

Questions worth asking out loud:

• “Based on what, exactly, are you recommending this?”
• “Do I need whole-body HRT, vaginal estrogen, a non-hormonal option, or an in-person check?”
• “Do I have any risk factor that changes the usual advice?”
• “If I have a uterus, what’s the plan to protect it?”
• “Is what you’re prescribing FDA-approved or compounded?”
• “What side effects should make me message you or go in person?”

What if the second opinion disagrees with your first doctor?

A simple way to compare the two, without spiraling:

If you want to go back to your first clinician, here’s a calm, copy-paste message that usually works:

And if you want an in-person menopause specialist, The Menopause Society keeps a public directory of clinicians who focus on this stage of life. (The Society lists them but doesn’t endorse individual practitioners.)

What real patients say

Women who finally feel heard tend to describe the same thing: a provider who listened and took their concerns seriously.

We share this as an example of patient experience only — not as proof of typical results, safety, or medical effectiveness, and we don’t attach star ratings to it. Your experience depends on your situation and the clinician you see.

Frequently asked questions

The bottom line

If your menopause plan doesn’t feel right, you’re allowed to get another opinion — and for many women, an online visit with a menopause-trained clinician is faster and more current than the appointment that let them down. Choose a live visit if you want a real review: Midi if you’re insured, Sesame for a cash visit with labs, or Evernow’s Pay-per-Visit for a true one-and-done. Skip straight to treatment with Winonaonly if you’ve already decided and don’t need the conversation. And if a red flag applies, start in person — that’s not a detour, that’s the safe route.

The right online HRT provider isn’t the same for every woman. Because a general answer can’t sort out your symptoms, your history, your insurance, and your state, use The HRT Index’s Find My HRT Path toolto match your situation to the right provider — and to flag when online care isn’t the right starting point — before your first consult.

The HRT Index is the independent menopause-HRT decision layer for women. This page is educational research and is not medical advice, and it has not been reviewed by a clinician. FDA-approved and compounded options are labeled separately throughout, and compounded hormones are never presented as safer than, more natural than, or equivalent to FDA-approved medication. Pricing and provider details were verified in June 2026 from each provider’s own materials and are re-checked on a fixed schedule — top providers monthly, the full roster quarterly. Because Find My HRT Path collects sensitive health information, it’s handled under our consumer-health-data and privacy policy.

Sources

• The Menopause Society (NAMS) 2022 Hormone Therapy Position Statement — menopause.org
• U.S. FDA, “FDA Approves Labeling Changes to Menopausal Hormone Therapy Products” (Feb 12, 2026) — fda.gov
• HHS/FDA boxed-warning announcement (Nov 10, 2025) — hhs.gov
• FDA consumer guidance on compounded “bioidentical” hormones — fda.gov
• Kling JM et al. (2019). Menopause management knowledge in postgraduate family medicine, internal medicine, and obstetrics and gynecology residents: a cross-sectional survey. Menopause, 26(3), 260–265.
• Allen RH et al. (2023). Menopause education in US OB/GYN residency programs. Menopause.
• Provider materials from Midi Health, Sesame, Winona, Hers, Inner Balance/Oestra, Evernow, and Gennev (verified June 2026).